Role of genetic modifiers on pulmonary consequences of cancer therapy in children.

Abstract excerpt

Childhood cancer survivors (CCS) often face late-onset adverse effects, with pulmonary complications being particularly common. In this study, we analyzed 104 CCS with pulmonary issues post-treatment using a genome-wide association study (GWAS) to identify genetic susceptibility markers. Among the cohort, 20% were diagnosed with interstitial lung disease (ILD), while other complications included pulmonary...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cancer Survivors
• Share to Child, Preschool
• Share to DNA Copy Number Variations